Skip to content

Vor Biopharma VOR Other current assets

Other current assets at other companies

Amgen logo
AmgenAMGN
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
TG Therapeutics logo
TG TherapeuticsTGTX
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%
Total assets$506.7M+364%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$784.61M+2,594%
Enterprise value$617.68M+5,866%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's other current assets?
Vor Biopharma (VOR) reported other current assets of $2.86M in Q1 2026.
How has Vor Biopharma's other current assets changed year-over-year?
Vor Biopharma's other current assets increased by 862.6% year-over-year, from $297K to $2.86M.
What is the long-term trend for Vor Biopharma's other current assets?
Over 5 years (2020 to 2025), Vor Biopharma's other current assets has grown at a 77.2% compound annual growth rate (CAGR), from $100K to $1.75M.